Related Experiment Video
Updated: May 28, 2026
07:34
Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis
Published on: December 30, 2025
Unusual site thrombosis
Marco P Donadini1, Walter Ageno
1Thrombosis Center, Division of Internal Medicine 1, Circolo Hospital-University of Insubria, Varese, Italy.
Seminars in Hematology
|October 18, 2011
Summary
Unusual site thrombosis, a rare venous thromboembolism (VTE) form, presents unique risks and requires tailored anticoagulant therapy. Evidence is limited, necessitating further research into optimal treatment and prognosis for these heterogeneous conditions.
Area of Science:
- Vascular Medicine
- Hematology
- Thrombosis Research
Background:
- Unusual site thrombosis (UST) represents rare and heterogeneous venous thromboembolism (VTE) manifestations.
- These conditions exhibit distinct pathophysiological and clinical features influenced by organ of origin.
- Risk factors for UST may differ from classical VTE like deep vein thrombosis or pulmonary embolism.
Purpose of the Study:
- To review the current understanding of unusual site thrombosis (UST).
- To highlight the challenges in managing UST due to limited evidence.
- To discuss the heterogeneity in prognosis and risk factors associated with UST.
Main Methods:
- Literature review of studies on unusual site thrombosis.
- Analysis of pathophysiological and clinical characteristics of UST.
- Evaluation of risk factors, treatment, and prognosis in UST.
Main Results:
- UST manifestations are diverse, with varying risk factors and clinical presentations.
- Anticoagulant therapy is indicated for UST, but optimal agents and duration remain debated.
- Prognosis, including recurrence and mortality, is heterogeneous and depends on predisposing causes.
Conclusions:
- Unusual site thrombosis (UST) requires specific management strategies due to its rarity and heterogeneity.
- Further research is crucial to establish evidence-based guidelines for optimal anticoagulant therapy and long-term care.
- Understanding predisposing factors is key to predicting prognosis in patients with UST.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.